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Background: A prophylactic antibiotic is recommended to reduce infection-related complication following
cesarean delivery. There is a current debate on the time of prophylactic antibiotic in cesarean delivery.
Methods: An opened randomized, controlled clinical trial was conducted at Soba hospital, Sudan to investigate the
timing (pre-incision or after clamping of the umbilical cord) of ceftizoxime for elective cesarean delivery. The
outcome measures were; the incidence of post-cesarean febrile and infection-related morbidity and neonatal
outcomes between the two groups.
Results: Hundred –eighty women (90 women in each arm of the study) received intravenous injection of 1 g of
ceftizoxime as single dose either at pre-incision or after clamping of the umbilical cord. None of the women in
either group had endometritis. One woman in the pre-incision group had chest infection. There was no significant
difference in the incidence of wound infection between the two groups, 8 (6.7%) vs. 3 (3.3%); P = 0.2. Two babies in
the pre-incision group (P = 0.497) had a low Apgar score (< 8) at 1 min. Similar number of neonate (15 in each arm)
was admitted to nursery. There were no significant difference in the neonatal jaundice between the two groups,
5 (5.5%) vs. 4 (4.4%), P = 0.2. There was no perinatal death.
Conclusions: There was no difference in the two regimens (pre-incision or post-clamping of the umbilical cord) of
ceftizoxime as prophylactic for elective cesarean delivery.
Trial registration: NCT01347593
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There is an increase in the incidence of cesarean delivery
and it is the most commonly performed major surgical
procedure [1]. Cesarean delivery is the most important
factor associated with postpartum infection, and carries
a 5 to 20-fold increased risk of infection compared with
vaginal delivery [2,3]. Wound infection is the most com-
mon infection-related complication following cesarean
delivery which can be reduced by the use of prophylactic
antibiotics [4].
Prophylactic antibiotics in women undergoing cesarean
delivery substantially reduced the incidence of febrile mor-
bidity [5]. Generally prophylactic antibiotics reduce surgical
site infections and it is recommended to be administrated* Correspondence: ishagadam@hotmail.com
2Department of Obstetrics and Gynecology, Faculty of Medicine, University
of Khartoum, P.O. Box 102, Khartoum, Sudan
Full list of author information is available at the end of the article
© 2013 Osman et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the orprior to surgical incision [6]. An exception to this pre-
incision prophylactic approach is cesarean delivery. Be-
cause of concerns about the sequelae of fetal antibiotic
exposure with pre-incision administration; the standard to
prevent post-cesarean infection has been the administra-
tion of antibiotic prophylaxis after delivery of the baby and
clamping of the umbilical cord [7]. Yet, recent observations
have challenged this policy of giving antibiotic prophylaxis
after delivery of the baby and clamping of the umbilical
cord [8]. Thus, there is a current debate on the time of
prophylactic antibiotic in cesarean delivery. Investigating
the time of prophylactic antibiotic in cesarean delivery is
highly needed before changing the policy from post-
clamping administration of prophylactic antibiotics to pre-
incision administration.
A first generation cephalosporin (cefazolin) has been
recommended as the regimen of choice for prophylactic
antibiotic in cesarean delivery because of increasingLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cephalosporins have been evaluated as prophylactic anti-
biotic in cesarean delivery with encouraging results [10].
Ceftizoxime (a 3rd generation cephalosporin) has shown
an excellent profile against surgical infecting organisms
[11]. The current study was conducted to investigate the
timing of prophylactic ceftizoxime for elective cesarean
delivery at Soba Hospital, Sudan and so as to add to the
previous reaches on prophylactic antibiotics for elective
cesarean delivery in Sudan [12].
Methods
A mono-centric opened randomized, controlled clinical
trial was carried- out during the period May –August
2011 at Soba Hospital.
Patients selection
Patients who were planned for elective cesarean delivery
for various reasons e.g. repeated scars, breech and low
lying placenta were enrolled in the study. Women were
excluded from the study if they had severe anaemia,
twins, diabetes mellitus, impaired glucose test, received
antibiotics within two weeks prior to the operation; if
they had any visible infection at any site or elevated
temperature at the time of the operation; if they were al-
lergic to drug used; or if they were not wish to partici-
pate in the study.
Treatment arms
Women were randomized by computer generated block-
randomization and concealed envelope system was used
to allocate the patients to receive intravenous injection
of 1 g of ceftizoxime as single dose either at the interval
of 40 minutes pre-incision or post -clamping the umbi-
lical cord. After giving consent, a complete history of the
participants was taken using a standard questionnaire. A
physical examination was performed.
Follow-up measurement
The primary outcome measure was the incidence of post-
operative febrile morbidity, defined as an oral temperature
of ≥ 38.0 °C on two occasions at least four hours apart, ex-
cluding the first 24 hours; it can be due to post-operativeTable 1 Indications of cesarean delivery in the two groups*
Indication of cesarean delivery Women who received pre-inci
ceftizoxime (n =90)
Repeated cesarean delivery 55 (61.1)
Breech presentation 10 (11.1)
Hypertensive disorder 2 (2.2)
Bad obstetrics events 7 (7.8)
Others 16 (17.8)
*data were shown as n (%).infection, which includes: endometritis (fever, uterine
tenderness and abnormal lochia), wound infection (fever,
cellulitis and exudates), pelvic abscess, peritonitis (elevated
temperature, tachycardia, abdominal distension and pain
with guarding and rigidity aggravated by moving and
breathing with absent bowel sounds at the onset of para-
lytic ileus) other febrile morbidity, e.g. urinary tract infec-
tion, chest infection, malaria [13].
Secondary outcome measures were the neonatal out-
comes: the incidence of low APGAR score (< 8) at 1 min,
neonatal jaundice and admission to the nursery.
Once febrile morbidity was identified, women were
examined thoroughly to localize the potential source of in-
fection (tonsils, breasts, chest, abdomen and pelvis). Urine
analysis (followed by urine culture and sensitivity testing if
the result of examination was suggestive of infection); total
white blood cell count. Blood and cervical swabs were sent
for culture (MacConkey Agar) and sensitivity testing.
Blood films (thin and thick) were taken by finger pricks
and Giemsa stained to confirm or to exclude malaria. The
policy in the hospital is to treat post-caesarean delivery
febrile morbidity (endometritis, peritonitis and pelvic
abscess) with amoxicillin + clavulanic acid and metronida-
zole 500 mg 8 hourly for 7 days. If there was no response,
these drugs were changed to antibiotics in accordance
with the result of the culture sensitivity test. If no compli-
cations, women were discharged from the hospital on the
fourth day and were instructed to presented at any time if
there is any complication, otherwise they were seen one,
two and 6 weeks later in the post delivery clinic where
they were examined for wound infection. The follow-up
was performed by a trained medical officer who was
blinded to the allocation to pre-incision or post-cord
clamping (to avoid bias).
Ethics
The study received ethical clearance from the Commit-
tee of Research Board of Soba Hospital, Sudan.
Statistical analyses
Data were entered in the computer using SPSS for win-
dows version16.0 and double checked before analysis.
Means and proportions of the socio-demographic andsion Women who received ceftizoxime







Table 2 Mean (SD) of the basic characteristics of women who received ceftizoxime as prophylaxis for elective cesarean
section
Variables Women who received pre-incision
ceftizoxime (n =90)
Women who received ceftizoxime
after clamping the umbilical cord (n =90)
P
Age, years 30.5 (7.4) 32.2 (5.2) 0.08
Gravidity 3.5 (1.6) 3.9 (2.1) 0.1
Parity 1.9 (1.5) 2.1 (1.5) 0.4
Weight, kg 77.4 (13.7) 79.4 (13.7) 0.3
Height, cm 158.3 (5.3) 159.6 (6.0) 0.1
Gestational age, weeks 38.2 (1.1) 38.3 (0.9) 0.7
Temperature, °C 36.9 (0.5) 36.9 (0.4) 0.5
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between the two groups using student t and X2 tests, re-
spectively. A probability value of < 0.05 was considered
as statistically significant.
Results
One hundred-eighty (90 women in each arm) women
were enrolled to the study for various indication of
cesarean delivery (Table 1). The two groups were well-
matched in the age, parity, weight, height, gestational age
and temperature (Table 2).
There is no significant difference in the maternal and
perinatal outcomes measures, (Table 3). While none of
the women who received ceftizoxime of after clamping
of the umbilical cord had post-operative febrile morbid-
ity, one woman who received the drug pre-incision had
post-operative febrile morbidity which was due to chest
infection (P = 0.3). None of the women in both groups
had endometritis. There was no significant difference in
the incidence of wound infection between the two
groups, 8 (6.7%) vs. 3 (3.3%); P = 0.2. All of these wound
infections observed during the follow-up after the
patients’ discharge from the hospital. While none of the
babies in the received ceftizoxime of after clamping of
the umbilical cord had low Apgar score (< 8) at 1 min,
two babies in the pre-incision group (P = 0.497) had low
Apgar score (<8) at 1 min. A Similar number of neonate
(15 in each arm of the study, P = 0.9) was admitted to
nursery (for the mean [SD] of 1.9 [0.7] vs. 1.7 [0.8]days;Table 3 Number (%) of maternal and perinatal outcome in wo
elective cesarean section
Variables Women who received ceftizo
pre-incision (n =90)
Post-operative febrile morbidity 1(1.1)
Superficial wound infection 8 (6.7)
Skin rash 0 (0)
Jaundice 5 (5.5)
Admission to the nursery 15 (16.7)p = 0.742 in the two groups, respectively) due to jaun-
dice, low Apgar score, low birth weight and for routine
check-up for those babies born to mothers with had bad
obstetric events. There were no significant difference in
the neonatal jaundice between the two groups, 5 (5.5%)
vs. 4(4.4%), P = 0.2.
Discussion
The main finding of the current study was; no significant
difference between the incidence of post-operative febrile
morbidity, superficial wound infections, neonatal jaundice
and neonatal admission to the nursery between the two
groups of women who received ceftizoxime either pre-
incision or after clamping of the umbilical cord. It has
been advised that prophylactic antibiotics should be given
before surgical incision to prevent post-operative surgical
infections [6]; an exception in this generalization is the
cesarean delivery, where the recommendation is to use
prophylactic antibiotics after clamping of the umbilical
cord. A recent survey that described practice of antibiotic
prophylaxis for cesarean delivery among American
maternal-fetal medicine physicians showed that; preope-
rative administration of antibiotic prophylaxis was the
commonest practice which was reported by 84.6% of the
physician compared to 15.0% who reported giving anti-
biotic prophylaxis after umbilical cord clamping [14].
The current debate of antibiotics commonly used for
cesarean prophylaxis is the concern that antibiotics rap-
idly transferred to the newborn and the fetal exposure tomen who received ceftizoxime as prophylaxis for
xime Women who received ceftizoxime
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possibility of the selection of resistant organisms [9].
Thus, sepsis work-ups on neonates who were exposed to
antibiotics immediately prior to the incision have been
practiced [15]. Furthermore, previous old studies of anti-
biotic prophylaxis for cesarean delivery suggested that,
while pre-incision administration did not reduce post-
cesarean infection, it did increase invasive neonatal
sepsis evaluations and costs [15,16]. However, recently
Kaimal et al., [17], in a cohort study of large number of
caesarean delivery (1316) reported that a policy change
in timing of antibiotic prophylaxis from post-clamping
to pre-incision resulted in a reduction of 60%, 50% and
80% in the rate of surgical site infection, endometritis
and cellulitis, respectively. Another recent study on a
change in policy from post-clamping administration of
prophylactic antibiotics to pre-incision administration
showed no difference incidence of endometritis (3.9% vs.
2.2%), and wound infection (3.6% vs. 2.5%) in the two
groups of women who received cefazolin post-clamping
antibiotics vs. pre-incision [18]. Moreover, recent study
documented that, the use of pre-incision antibiotics was
not associated with an increase in neonatal sepsis, sepsis
work-up, and admission or length of stay in the Neonatal
Intensive Care Unit [19].
In the current study, there were 6.7% vs. 3.3%, P = 0.2
wound infection in the group of women who received
ceftizoxime post-clamping antibiotics vs. pre-incision. The
diagnose of these wound infections during the follow-up
period after the patients discharged might indicate the
true incidence of these events. Previous study showed that,
up to 80% of infections occur after discharge from the
hospital [20-22]. Thus, post- cesarean deliveries infection
rates may be underestimated if based on hospital dis-
charge records. The prevalence of wound infection varies
according to the setting itself and it was reported
among10% of cesarean deliveries despite recommended
antibiotic prophylaxis [7,20,21].
In the current study 15 babies in each arm of the study
were admitted to the nursery. Perhaps, these rates might
has been influenced by the decision of the operation itself
where 19 of these cesarean deliveries were performed for
bad obstetrical events i.e. on the baby’s behalf.Study limitations
One limitation of this study is the sample size was not
powered to show either equivalence or superiority as the
sample size was not calculated to address these; perhaps
larger size study (around 4000 patients) is needed to
according to open Epio-epidemioligic calculator [23], with
the proportion of those women with post-operative febrile
morbidity (2 vs. 3%) within 3–5 percentage points of the
true proportion and 80% power. The other limitations ofthis study were; cost was not investigated and there was
no other type of antibiotic used as control.
Conclusion
Both regimens of pre-incision or post-clamping of the
umbilical cord of ceftizoxime were effective prophylactic
for elective cesarean delivery.
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